21Mar/17

BioLineRx Provides Update on Phase 2 Open-Label Study for BL-8040 as Novel Stem Cell Mobilization Treatment – PharmiWeb.com (press release)

BioLineRx Provides Update on Phase 2 Open-Label Study for BL-8040 as Novel Stem Cell Mobilization Treatment
PharmiWeb.com (press release)
An allogeneic hematopoietic cell transplant involves matching a patient’s tissue type, specifically their human leukocyte antigen (HLA) tissue type, with that of a related or unrelated donor. HLA proteins are found on all cells of our body and are the

and more »

21Mar/17

Red Cross: Blood Donation Need Is Urgent | News, Sports, Jobs … – Jamestown Post Journal

Tucson Local MediaRed Cross: Blood Donation Need Is Urgent | News, Sports, Jobs …Jamestown Post JournalThe American Red Cross is urging all eligible donors throughout the New York-Penn Region to give blood or platelets following the recent winter sto…